{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Eleutherococcus senticosus", "Rhodiola rosea", "Schisandra chinensis", "Withania somnifera", "adaptogen", "neuroinflammation", "pharmacological effects"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38398618", "DateCompleted": {"Year": "2024", "Month": "02", "Day": "26"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "27"}, "Article": {"Language": ["eng"], "ELocationID": ["866", "10.3390/molecules29040866"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "15"}], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "29", "Issue": "4", "PubDate": {"Year": "2024", "Month": "Feb", "Day": "15"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Anti-Neuroinflammatory Effects of Adaptogens: A Mini-Review.", "Abstract": {"AbstractText": ["<b>Introduction</b>: Adaptogens are a group of plants that exhibit complex, nonspecific effects on the human body, increasing its ability to adapt, develop resilience, and survive in stress conditions. They are found in many traditional medicinal systems and play a key role in restoring the body's strength and stamina. Research in recent years has attempted to elucidate the mechanisms behind their pharmacological effects, but it appears that these effects are difficult to define precisely and involve multiple molecular pathways. <b>Neuroinflammation</b>: In recent years, chronic inflammation has been recognized as one of the common features of many central nervous system disorders (dementia and other neurodegenerative diseases, depression, anxiety, ischemic stroke, and infections). Because of the specific nature of the brain, this process is called neuroinflammation, and its suppression can result in an improvement of patients' condition and may promote their recovery. <b>Adaptogens as anti-inflammatory agents</b>: As has been discovered, adaptogens display anti-inflammatory effects, which suggests that their application may be broader than previously thought. They regulate gene expression of anti- and proinflammatory cytokines (prostaglandins, leukotriens) and can modulate signaling pathways (e.g., NF-\u03baB). <b>Aim</b>: This mini-review aims to present the anti-neuroinflammatory potential of the most important plants classified as adaptogens: <i>Schisandra chinensis</i>, <i>Eleutherococcus senticosus</i>, <i>Rhodiola rosea</i> and <i>Withania somnifera</i>."]}, "AuthorList": [{"Identifier": ["0000-0001-9780-7924"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Jagiellonian University Collegium Medicum, Medyczna 9, 30-688 Cracow, Poland."}], "LastName": "Wr\u00f3bel-Biedrawa", "ForeName": "Dagmara", "Initials": "D"}, {"Identifier": ["0000-0002-1251-7192"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Jagiellonian University Collegium Medicum, Medyczna 9, 30-688 Cracow, Poland."}], "LastName": "Podolak", "ForeName": "Irma", "Initials": "I"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Neuroinflammatory Diseases"}, {"QualifierName": [], "DescriptorName": "Adaptation, Physiological"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Rhodiola"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Winston D. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Simon and Schuster; New York, NY, USA: 2019."}, {"Citation": "Tewari N., Verma L., Jawaid T. Adaptogenic agents: A review. Int. J. Biomed. Res. 2011;5:285\u2013304."}, {"Citation": "Todorova V., Ivanov K., Delattre C., Nalbantova V., Karcheva-Bahchevanska D., Ivanova S. Plant adaptogens\u2014History and future perspectives. Nutrients. 2021;13:2861. doi: 10.3390/nu13082861.", "ArticleIdList": ["10.3390/nu13082861", "PMC8398443", "34445021"]}, {"Citation": "Panossian A., Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr. Clin. Pharmacol. 2009;4:198\u2013219. doi: 10.2174/157488409789375311.", "ArticleIdList": ["10.2174/157488409789375311", "19500070"]}, {"Citation": "Panossian A., Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress\u2014Protective activity. Pharmaceuticals. 2010;3:188\u2013224. doi: 10.3390/ph3010188.", "ArticleIdList": ["10.3390/ph3010188", "PMC3991026", "27713248"]}, {"Citation": "Panossian A., Seo E.J., Efferth T. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells. Phytomedicine. 2019;60:152881. doi: 10.1016/j.phymed.2019.152881.", "ArticleIdList": ["10.1016/j.phymed.2019.152881", "30987861"]}, {"Citation": "Kim J.H., Yi Y.S., Kim M.Y., Cho J.Y. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J. Ginseng Res. 2017;41:435\u2013443. doi: 10.1016/j.jgr.2016.08.004.", "ArticleIdList": ["10.1016/j.jgr.2016.08.004", "PMC5628327", "29021688"]}, {"Citation": "Panossian A. Understanding adaptogenic activity: Specificity of the pharmacological action of adaptogens and other phytochemicals. Ann. N. Y. Acad. Sci. 2017;1401:49\u201364. doi: 10.1111/nyas.13399.", "ArticleIdList": ["10.1111/nyas.13399", "28640972"]}, {"Citation": "Tiwari S., Atluri V., Kaushik A., Yndart A., Nair M. Alzheimer\u2019s disease: Pathogenesis, diagnostics, and therapeutics. Int. J. Nanomed. 2019;14:5541\u20135554. doi: 10.2147/IJN.S200490.", "ArticleIdList": ["10.2147/IJN.S200490", "PMC6650620", "31410002"]}, {"Citation": "Kouli A., Torsney K.M., Kuan W.L. Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis. Exon Publications; Brisbane, Australia: 2018. pp. 3\u201326."}, {"Citation": "Bano D., Zanetti F., Mende Y., Nicotera P. Neurodegenerative processes in Huntington\u2019s disease. Cell Death Dis. 2011;2:e228. doi: 10.1038/cddis.2011.112.", "ArticleIdList": ["10.1038/cddis.2011.112", "PMC3223696", "22071633"]}, {"Citation": "Ghasemi N., Razavi S., Nikzad E. Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. (Yakhteh) 2017;19:1\u201310.", "ArticleIdList": ["PMC5241505", "28367411"]}, {"Citation": "Tartt A.N., Mariani M.B., Hen R., Mann J.J., Boldrini M. Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications. Mol. Psychiatry. 2022;27:2689\u20132699. doi: 10.1038/s41380-022-01520-y.", "ArticleIdList": ["10.1038/s41380-022-01520-y", "PMC9167750", "35354926"]}, {"Citation": "Baldwin D., Stein M.B., Hermann R.  Generalized Anxiety Disorder in Adults: Epidemiology, Pathogenesis, Clinical Manifestations, Course, Assessment, and Diagnosis. UpToDate; Waltham, MA, USA: 2018.  [(accessed on 11 December 2023)].  Available online:  https://medilib.ir/uptodate/show/496."}, {"Citation": "Jaffe A.E., Straub R.E., Shin J.H., Tao R., Gao Y., Collado-Torres L., Weinberger D.R. Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis. Nat. Neurosci. 2018;21:1117\u20131125. doi: 10.1038/s41593-018-0197-y.", "ArticleIdList": ["10.1038/s41593-018-0197-y", "PMC6438700", "30050107"]}, {"Citation": "Stanzione R., Cotugno M., Bianchi F., Marchitti S., Forte M., Volpe M., Rubattu S. Pathogenesis of ischemic stroke: Role of epigenetic mechanisms. Genes. 2020;11:89. doi: 10.3390/genes11010089.", "ArticleIdList": ["10.3390/genes11010089", "PMC7017187", "31941075"]}, {"Citation": "Forrester J.V., McMenamin P.G., Dando S.J. CNS infection and immune privilege. Nat. Rev. Neurosci. 2018;19:655\u2013671. doi: 10.1038/s41583-018-0070-8.", "ArticleIdList": ["10.1038/s41583-018-0070-8", "30310148"]}, {"Citation": "Blackadar C.B. Historical review of the causes of cancer. World J. Clin. Oncol. 2016;7:54. doi: 10.5306/wjco.v7.i1.54.", "ArticleIdList": ["10.5306/wjco.v7.i1.54", "PMC4734938", "26862491"]}, {"Citation": "Afshari K., Dehdashtian A., Haddadi N.S., Haj-Mirzaian A., Iranmehr A., Ebrahimi M.A., Dehpour A.R. Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: Introduction of an alternative therapy. Spinal Cord. 2018;56:1032\u20131041. doi: 10.1038/s41393-018-0168-x.", "ArticleIdList": ["10.1038/s41393-018-0168-x", "29959433"]}, {"Citation": "Yu J., Wang W.N., Matei N., Li X., Pang J.W., Mo J., Zhang J.H. Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK/Nrf2/TXNIP pathway after MCAO in rats. Oxidative Med. Cell. Longev. 2020;2020:4717258. doi: 10.1155/2020/4717258.", "ArticleIdList": ["10.1155/2020/4717258", "PMC6964721", "31998437"]}, {"Citation": "Dionisie V., Filip G.A., Manea M.C., Manea M., Riga S. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: A review of human and rodent research studies. Inflammopharmacology. 2021;29:75\u201390. doi: 10.1007/s10787-020-00777-5.", "ArticleIdList": ["10.1007/s10787-020-00777-5", "33164143"]}, {"Citation": "Kaur N., Chugh H., Sakharkar M.K., Dhawan U., Chidambaram S.B., Chandra R. Neuroinflammation mechanisms and phytotherapeutic intervention: A systematic review. ACS Chem. Neurosci. 2020;11:3707\u20133731. doi: 10.1021/acschemneuro.0c00427.", "ArticleIdList": ["10.1021/acschemneuro.0c00427", "33146995"]}, {"Citation": "Zahedipour F., Hosseini S.A., Henney N.C., Barreto G.E., Sahebkar A. Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases. Neural Regen. Res. 2022;17:1675.", "ArticleIdList": ["PMC8820712", "35017414"]}, {"Citation": "Yu Y., Shen Q., Lai Y., Park S.Y., Ou X., Lin D., Zhang W. Anti-inflammatory effects of curcumin in microglial cells. Front. Pharmacol. 2018;9:386. doi: 10.3389/fphar.2018.00386.", "ArticleIdList": ["10.3389/fphar.2018.00386", "PMC5922181", "29731715"]}, {"Citation": "Zhang J., Zheng Y., Luo Y., Du Y., Zhang X., Fu J. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-\u03baB pathways in BV2 cells. Mol. Immunol. 2019;116:29\u201337. doi: 10.1016/j.molimm.2019.09.020.", "ArticleIdList": ["10.1016/j.molimm.2019.09.020", "31590042"]}, {"Citation": "Park G., Kim H.G., Ju M.S., Ha S.K., Park Y., Kim S.Y., Oh M.S. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson\u2019s disease models via anti-neuroinflammation. Acta Pharmacol. Sin. 2013;34:1131\u20131139. doi: 10.1038/aps.2013.57.", "ArticleIdList": ["10.1038/aps.2013.57", "PMC4003157", "23811724"]}, {"Citation": "Zhong X., Liu M., Yao W., Du K., He M., Jin X., Wei M. Epigallocatechin-3-gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of canonical and noncanonical inflammasome via TLR4/NF-\u03baB pathway. Mol. Nutr. Food Res. 2019;63:1801230. doi: 10.1002/mnfr.201801230.", "ArticleIdList": ["10.1002/mnfr.201801230", "31374144"]}, {"Citation": "Zhang F., Wang H., Wu Q., Lu Y., Nie J., Xie X., Shi J. Resveratrol protects cortical neurons against microglia-mediated euroinflammation. Phytother. Res. 2013;27:344\u2013349. doi: 10.1002/ptr.4734.", "ArticleIdList": ["10.1002/ptr.4734", "22585561"]}, {"Citation": "Bhandari R., Kuhad A. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders. Neurochem. Int. 2017;103:8\u201323. doi: 10.1016/j.neuint.2016.12.012.", "ArticleIdList": ["10.1016/j.neuint.2016.12.012", "28025035"]}, {"Citation": "Yao Z.H., Yao X.L., Zhang Y., Zhang S.F., Hu J.C. Luteolin could improve cognitive dysfunction by inhibiting neuroinflammation. Neurochem. Res. 2018;43:806\u2013820. doi: 10.1007/s11064-018-2482-2.", "ArticleIdList": ["10.1007/s11064-018-2482-2", "29392519"]}, {"Citation": "Jo S.H., Kim M.E., Cho J.H., Lee Y., Lee J., Park Y.D., Lee J.S. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways. Arch. Pharmacal Res. 2019;42:695\u2013703. doi: 10.1007/s12272-019-01174-5.", "ArticleIdList": ["10.1007/s12272-019-01174-5", "31327152"]}, {"Citation": "Kang A., Xie T., Zhu D., Shan J., Di L., Zheng X. Suppressive effect of ginsenoside Rg3 against lipopolysaccharide-induced depression-like behavior and neuroinflammation in mice. J. Agric. Food Chem. 2017;65:6861\u20136869. doi: 10.1021/acs.jafc.7b02386.", "ArticleIdList": ["10.1021/acs.jafc.7b02386", "28762741"]}, {"Citation": "Wang S., Jing H., Yang H., Liu Z., Guo H., Chai L., Hu L. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u05f3 s disease. J. Ethnopharmacol. 2015;164:247\u2013255. doi: 10.1016/j.jep.2015.01.042.", "ArticleIdList": ["10.1016/j.jep.2015.01.042", "25666429"]}, {"Citation": "Zhang Z., Li X., Li F., An L. Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice. Int. Immunopharmacol. 2016;38:426\u2013433. doi: 10.1016/j.intimp.2016.06.031.", "ArticleIdList": ["10.1016/j.intimp.2016.06.031", "27376853"]}, {"Citation": "Nathan C. Points of control in inflammation. Nature. 2002;420:846\u2013852. doi: 10.1038/nature01320.", "ArticleIdList": ["10.1038/nature01320", "12490957"]}, {"Citation": "Lyman M., Lloyd D.G., Ji X., Vizcaychipi M.P., Ma D. Neuroinflammation: The role and consequences. Neurosci. Res. 2014;79:1\u201312. doi: 10.1016/j.neures.2013.10.004.", "ArticleIdList": ["10.1016/j.neures.2013.10.004", "24144733"]}, {"Citation": "Shabab T., Khanabdali R., Moghadamtousi S.Z., Kadir H.A., Mohan G. Neuroinflammation pathways: A general review. Int. J. Neurosci. 2017;127:624\u2013633. doi: 10.1080/00207454.2016.1212854.", "ArticleIdList": ["10.1080/00207454.2016.1212854", "27412492"]}, {"Citation": "Yang Q.Q., Zhou J.W. Neuroinflammation in the central nervous system: Symphony of glial cells. Glia. 2019;67:1017\u20131035. doi: 10.1002/glia.23571.", "ArticleIdList": ["10.1002/glia.23571", "30548343"]}, {"Citation": "Jain M., Singh M.K., Shyam H., Mishra A., Kumar S., Kumar A., Kushwaha J. Role of JAK/STAT in the neuroinflammation and its association with neurological disorders. Ann. Neurosci. 2021;28:191\u2013200. doi: 10.1177/09727531211070532.", "ArticleIdList": ["10.1177/09727531211070532", "PMC8948319", "35341232"]}, {"Citation": "Guo H., Callaway J.B., Ting J.P. Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat. Med. 2015;21:677\u2013687. doi: 10.1038/nm.3893.", "ArticleIdList": ["10.1038/nm.3893", "PMC4519035", "26121197"]}, {"Citation": "A\u00efd S., Bosetti F. Targeting cyclooxygenases-1 and-2 in neuroinflammation: Therapeutic implications. Biochimie. 2011;93:46\u201351. doi: 10.1016/j.biochi.2010.09.009.", "ArticleIdList": ["10.1016/j.biochi.2010.09.009", "PMC3008299", "20868723"]}, {"Citation": "Khan A., Ikram M., Muhammad T., Park J., Kim M.O. Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2/HO-1 in vivo and in vitro. J. Clin. Med. 2019;8:680. doi: 10.3390/jcm8050680.", "ArticleIdList": ["10.3390/jcm8050680", "PMC6572702", "31091792"]}, {"Citation": "Singh V., Roth S., Llovera G., Sadler R., Garzetti D., Stecher B., Liesz A. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J. Neurosci. 2016;36:7428\u20137440. doi: 10.1523/JNEUROSCI.1114-16.2016.", "ArticleIdList": ["10.1523/JNEUROSCI.1114-16.2016", "PMC6705544", "27413153"]}, {"Citation": "Global Biodiversity Information Facility.  [(accessed on 30 November 2023)].  Available online:  https://www.gbif.org/species/search."}, {"Citation": "Wang X., Wang X., Yao H., Shen C., Geng K., Xie H. A comprehensive review on Schisandrin and its pharmacological features. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2023;397:783\u2013794. doi: 10.1007/s00210-023-02687-z.", "ArticleIdList": ["10.1007/s00210-023-02687-z", "37658213"]}, {"Citation": "Szopa A., Ekiert R., Ekiert H. Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: A review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem. Rev. 2017;16:195\u2013218. doi: 10.1007/s11101-016-9470-4.", "ArticleIdList": ["10.1007/s11101-016-9470-4", "PMC5378736", "28424569"]}, {"Citation": "Sowndhararajan K., Deepa P., Kim M., Park S.J., Kim S. An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis. Biomed. Pharmacother. 2018;97:958\u2013968. doi: 10.1016/j.biopha.2017.10.145.", "ArticleIdList": ["10.1016/j.biopha.2017.10.145", "29136774"]}, {"Citation": "Zhang M., Xu L., Yang H. Schisandra chinensis fructus and its active ingredients as promising resources for the treatment of neurological diseases. Int. J. Mol. Sci. 2018;19:1970. doi: 10.3390/ijms19071970.", "ArticleIdList": ["10.3390/ijms19071970", "PMC6073455", "29986408"]}, {"Citation": "Zhou Y., Men L., Sun Y., Wei M., Fan X. Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz.(Baill.), a current review. Eur. J. Pharmacol. 2021;892:173796. doi: 10.1016/j.ejphar.2020.173796.", "ArticleIdList": ["10.1016/j.ejphar.2020.173796", "33345853"]}, {"Citation": "Zhao X., Liu C., Xu M., Li X., Bi K., Jia Y. Total lignans of Schisandra chinensis ameliorates A\u03b21-42-induced neurodegeneration with cognitive impairment in mice and primary mouse neuronal cells. PLoS ONE. 2016;11:e0152772. doi: 10.1371/journal.pone.0152772.", "ArticleIdList": ["10.1371/journal.pone.0152772", "PMC4818042", "27035824"]}, {"Citation": "Park S.Y., Park S.J., Park T.G., Rajasekar S., Lee S.J., Choi Y.W. Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia. Int. Immunopharmacol. 2013;17:415\u2013426. doi: 10.1016/j.intimp.2013.06.032.", "ArticleIdList": ["10.1016/j.intimp.2013.06.032", "23859871"]}, {"Citation": "Joo S.S., Yoo Y.M., Won T.J., Kim M.J., Lee S.G., Hwang K.W., Lee D.I. Regulation of Inflammatory Repertoires and NF-\u03baB Signal Transduction by DDB, an Active Compound from Schizandra Chinensis Baillon. Immune Netw. 2006;6:27\u201332. doi: 10.4110/in.2006.6.1.27.", "ArticleIdList": ["10.4110/in.2006.6.1.27"]}, {"Citation": "Song F., Zeng K., Liao L., Yu Q., Tu P., Wang X. Schizandrin A inhibits microglia-mediated neuroninflammation through inhibiting TRAF6-NF-\u03baB and Jak2-Stat3 signaling pathways. PLoS ONE. 2016;11:e0149991. doi: 10.1371/journal.pone.0149991.", "ArticleIdList": ["10.1371/journal.pone.0149991", "PMC4768966", "26919063"]}, {"Citation": "Liu N., Zheng J.X., Zhuang Y.S., Zhou Z.K., Zhao J.H., Yang L. Anti-inflammatory effects of schisandrin B on LPS-stimulated BV2 microglia via activating PPAR-\u03b3. Inflammation. 2017;40:1006\u20131011. doi: 10.1007/s10753-017-0544-2.", "ArticleIdList": ["10.1007/s10753-017-0544-2", "28303415"]}, {"Citation": "Araki R., Hiraki Y., Nishida S., Inatomi Y., Yabe T. Gomisin N ameliorates lipopolysaccharide-induced depressive-like behaviors by attenuating inflammation in the hypothalamic paraventricular nucleus and central nucleus of the amygdala in mice. J. Pharmacol. Sci. 2016;132:138\u2013144. doi: 10.1016/j.jphs.2016.09.004.", "ArticleIdList": ["10.1016/j.jphs.2016.09.004", "27733273"]}, {"Citation": "Fan X., Elkin K., Shi Y., Zhang Z., Cheng Y., Gu J., Ji X. Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-\u03baB signaling pathway inhibition. Neurol. Res. 2020;42:693\u2013702. doi: 10.1080/01616412.2020.1782079.", "ArticleIdList": ["10.1080/01616412.2020.1782079", "32657248"]}, {"Citation": "Chen S., Ding Y.H., Shi S.S., Tu X.K. Schisandrin B inhibits NLRP3 inflammasome pathway and attenuates early brain injury in rats of subarachnoid hemorrhage. Chin. J. Integr. Med. 2022;28:594\u2013602. doi: 10.1007/s11655-021-3348-z.", "ArticleIdList": ["10.1007/s11655-021-3348-z", "35015222"]}, {"Citation": "Lam H.Y.P., Liang T.R., Jiang S.J., Peng S.Y. Albendazole-schisandrin B co-therapy on Angiostrongylus cantonensis-induced meningoencephalitis in mice. Biomolecules. 2020;10:1001. doi: 10.3390/biom10071001.", "ArticleIdList": ["10.3390/biom10071001", "PMC7407957", "32635653"]}, {"Citation": "Li Q., Wang Q., Guan H., Zhou Y., Liu L. Neuropsychiatric Disease and Treatment. Taylor & Francis; Abingdon, UK: 2021. Schisandrin inhibits NLRP1 inflammasome-mediated neuronal pyroptosis in mouse models of Alzheimer\u2019s disease; pp. 261\u2013268.", "ArticleIdList": ["PMC7853410", "33542629"]}, {"Citation": "Song L., Piao Z., Yao L., Zhang L., Lu Y. Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer\u2019s disease rats. Exp. Anim. 2020;69:363\u2013373. doi: 10.1538/expanim.19-0146.", "ArticleIdList": ["10.1538/expanim.19-0146", "PMC7445059", "32336744"]}, {"Citation": "Wang J., Zhang G., Yang Y., Zhang X., Shi K., Zhang X., Jia Y. Schisandra chinensis Lignans Exert Antidepressant Effects by Promoting BV2 Microglia Polarization toward the M2 Phenotype through the Activation of the Cannabinoid Receptor Type-2\u2013Signal Transducer and Activator of Transcription 6 Pathway. J. Agric. Food Chem. 2022;70:14157\u201314169. doi: 10.1021/acs.jafc.2c04565.", "ArticleIdList": ["10.1021/acs.jafc.2c04565", "36349542"]}, {"Citation": "Wang X., Hu D., Zhang L., Lian G., Zhao S., Wang C., Yang J. Gomisin A inhibits lipopolysaccharide-induced inflammatory responses in N9 microglia via blocking the NF-\u03baB/MAPKs pathway. Food Chem. Toxicol. 2014;63:119\u2013127. doi: 10.1016/j.fct.2013.10.048.", "ArticleIdList": ["10.1016/j.fct.2013.10.048", "24211520"]}, {"Citation": "Xu X.L., Li S., Zhang R., Le W.D. Neuroprotective effects of naturally sourced bioactive polysaccharides: An update. Neural Regen. Res. 2022;17:1907.", "ArticleIdList": ["PMC8848587", "35142666"]}, {"Citation": "Fu J., Li J., Sun Y., Liu S., Song F., Liu Z. An integrated study on the comprehensive mechanism of Schisandra chinensis polysaccharides mitigating Alzheimer\u2019s disease in rats using a UPLC-Q-TOF-MS based serum and urine metabolomics strategy. Food Funct. 2023;14:734\u2013745. doi: 10.1039/D2FO02842E.", "ArticleIdList": ["10.1039/D2FO02842E", "36562313"]}, {"Citation": "Xu M., Zhang X., Ren F., Yan T., Wu B., Bi K., Jia Y. Essential oil of Schisandra chinensis ameliorates cognitive decline in mice by alleviating inflammation. Food Funct. 2019;10:5827\u20135842. doi: 10.1039/C9FO00058E.", "ArticleIdList": ["10.1039/C9FO00058E", "31463498"]}, {"Citation": "Jang M., Choi J.H., Jang D.S., Cho I.H. Micrandilactone C, a Nortriterpenoid Isolated from Roots of Schisandra chinensis, Ameliorates Huntington\u2019s Disease by Inhibiting Microglial STAT3 Pathways. Cells. 2023;12:786. doi: 10.3390/cells12050786.", "ArticleIdList": ["10.3390/cells12050786", "PMC10000367", "36899922"]}, {"Citation": "Davydov M., Krikorian A.D. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: A closer look. J. Ethnopharmacol. 2000;72:345\u2013393.", "ArticleIdList": ["10996277"]}, {"Citation": "Solomonova E., Trusov N., Nozdrina T. Opportunities for using of eleutherococcuses fruits as a new food raw material; Proceedings of the 1st International Symposium Innovations in Life Sciences (ISILS 2019); Belgorod, Russia. 10\u201311 October 2019; Cambridge, MA, USA: Atlantis Press; 2019. pp. 24\u201328."}, {"Citation": "Huang Y.H., Li J.T., Zan K., Wang J., Fu Q. The traditional uses, secondary metabolites, and pharmacology of Eleutherococcus species. Phytochem. Rev. 2022;21:1081\u20131184. doi: 10.1007/s11101-021-09775-z.", "ArticleIdList": ["10.1007/s11101-021-09775-z"]}, {"Citation": "Li X.T., Zhou J.C., Zhou Y., Ren Y.S., Huang Y.H., Wang S.M., Ge Y.W. Pharmacological effects of Eleutherococcus senticosus on the neurological disorders. Phytother. Res. 2022;36:3490\u20133504. doi: 10.1002/ptr.7555.", "ArticleIdList": ["10.1002/ptr.7555", "35844057"]}, {"Citation": "Jin L., Schmiech M., El Gaafary M., Zhang X., Syrovets T., Simmet T. A comparative study on root and bark extracts of Eleutherococcus senticosus and their effects on human macrophages. Phytomedicine. 2020;68:153181. doi: 10.1016/j.phymed.2020.153181.", "ArticleIdList": ["10.1016/j.phymed.2020.153181", "32065954"]}, {"Citation": "Graczyk F., Orzechowska B., Franz D., Strzemski M., Verpoorte R., Za\u0142uski D. The intractum from the Eleutherococcus senticosus fruits affects the innate immunity in human leukocytes: From the ethnomedicinal use to contemporary evidence-based research. J. Ethnopharmacol. 2021;268:113636. doi: 10.1016/j.jep.2020.113636.", "ArticleIdList": ["10.1016/j.jep.2020.113636", "33271247"]}, {"Citation": "Ahmed S., Moni D.A., Sonawane K.D., Paek K.Y., Shohael A.M. A comprehensive in silico exploration of pharmacological properties, bioactivities and COX-2 inhibitory potential of eleutheroside B from Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. J. Biomol. Struct. Dyn. 2021;39:6553\u20136566.", "ArticleIdList": ["32757816"]}, {"Citation": "Lee D., Park J., Yoon J., Kim M.Y., Choi H.Y., Kim H. Neuroprotective effects of Eleutherococcus senticosus bark on transient global cerebral ischemia in rats. J. Ethnopharmacol. 2012;139:6\u201311. doi: 10.1016/j.jep.2011.05.024.", "ArticleIdList": ["10.1016/j.jep.2011.05.024", "21645606"]}, {"Citation": "Wang R., Liu S., Liu T., Wu J., Zhang H., Sun Z., Liu Z. Mass spectrometry-based serum lipidomics strategy to explore the mechanism of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. Leaves Treat. Ischemic Stroke. Food Funct. 2021;12:4519\u20134534.", "ArticleIdList": ["33890948"]}, {"Citation": "Wang R., Sun Y., Wang M., Li H., Liu S., Liu Z. Therapeutic effect of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. Leaves Ischemic Stroke Via Microbiota\u2013Gut\u2013Brain Axis. Phytother. Res. 2023;37:4801\u20134818.", "ArticleIdList": ["37518502"]}, {"Citation": "Huang Y.H., Ding W.L., Li X.T., Cai M.T., Li H.L., Yang Z.Y., Ge Y.W. Memory enhancement effect of saponins from Eleutherococcus senticosus leaves and blood\u2013brain barrier-permeated saponins profiling using a pseudotargeted monitoring strategy. Food Funct. 2022;13:3603\u20133620. doi: 10.1039/D1FO03078G.", "ArticleIdList": ["10.1039/D1FO03078G", "35262106"]}, {"Citation": "Jagtap P.N., Mhetre O.S., Malavdkar P.R. A Review Article on Rhodiola Rosea: An Adaptogen Having Multiple Benefits. Int. J. Pharmacogn. 2020;7:62\u201369."}, {"Citation": "Bernatoniene J., Jakstas V., Kopustinskiene D.M. Phenolic compounds of Rhodiola rosea L. as the potential alternative therapy in the treatment of chronic diseases. Int. J. Mol. Sci. 2023;24:12293. doi: 10.3390/ijms241512293.", "ArticleIdList": ["10.3390/ijms241512293", "PMC10418374", "37569669"]}, {"Citation": "Lee Y., Jung J.C., Jang S., Kim J., Ali Z., Khan I.A., Oh S. Anti-inflammatory and neuroprotective effects of constituents isolated from Rhodiola rosea. Evid. Based Complement. Altern. Med. 2013;2013:514049.", "ArticleIdList": ["PMC3652169", "23690847"]}, {"Citation": "Borgonetti V., Governa P., Biagi M., Dalia P., Corsi L. Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model. Phytomedicine. 2020;68:153143. doi: 10.1016/j.phymed.2019.153143.", "ArticleIdList": ["10.1016/j.phymed.2019.153143", "32018209"]}, {"Citation": "Lin X., Liu Y., Ma L., Ma X., Chen Z., Chen H., Chen X. Amelioration of experimental autoimmune encephalomyelitis by Rhodiola rosea, a natural adaptogen. Biomed. Pharmacother. 2020;125:109960. doi: 10.1016/j.biopha.2020.109960.", "ArticleIdList": ["10.1016/j.biopha.2020.109960", "32058218"]}, {"Citation": "Li Y., Cai M., Mao G.X., Shu Q.F., Liu X.B., Liu X.L. Preclinical evidence and possible mechanisms of Rhodiola rosea L. and its components for ischemic stroke: A systematic review and meta-analysis. Front. Pharmacol. 2021;12:736198. doi: 10.3389/fphar.2021.736198.", "ArticleIdList": ["10.3389/fphar.2021.736198", "PMC8602078", "34803686"]}, {"Citation": "El Maadawi Z.M. Conditioned medium derived from salidroside-pretreated mesenchymal stem cell culture ameliorates mouse lipopolysaccharide-induced cerebral neuroinflammation-histological and immunohistochemical study. Int. J. Stem Cells. 2017;10:60. doi: 10.15283/ijsc16055.", "ArticleIdList": ["10.15283/ijsc16055", "PMC5488777", "28446004"]}, {"Citation": "Zhang X., Lai W., Ying X., Xu L., Chu K., Brown J., Hong G. Salidroside reduces inflammation and brain injury after permanent middle cerebral artery occlusion in rats by regulating PI3K/PKB/Nrf2/NF\u03baB signaling rather than complement C3 activity. Inflammation. 2019;42:1830\u20131842. doi: 10.1007/s10753-019-01045-7.", "ArticleIdList": ["10.1007/s10753-019-01045-7", "31230155"]}, {"Citation": "Xu N., Huang F., Jian C., Qin L., Lu F., Wang Y., Zhang Q. Neuroprotective effect of salidroside against central nervous system inflammation-induced cognitive deficits: A pivotal role of sirtuin 1-dependent N rf-2/HO-1/NF-\u03ba B pathway. Phytother. Res. 2019;33:1438\u20131447. doi: 10.1002/ptr.6335.", "ArticleIdList": ["10.1002/ptr.6335", "30848530"]}, {"Citation": "Ng Q.X., Loke W., Foo N.X., Tan W.J., Chan H.W., Lim D.Y., Yeo W.S. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother. Res. 2020;34:583\u2013590. doi: 10.1002/ptr.6552.", "ArticleIdList": ["10.1002/ptr.6552", "31742775"]}, {"Citation": "Speers A.B., Cabey K.A., Soumyanath A., Wright K.M. Effects of Withania somnifera (Ashwagandha) on stress and the stress-related neuropsychiatric disorders anxiety, depression, and insomnia. Curr. Neuropharmacol. 2021;19:1468. doi: 10.2174/1570159X19666210712151556.", "ArticleIdList": ["10.2174/1570159X19666210712151556", "PMC8762185", "34254920"]}, {"Citation": "Elhadidy M.E., Sawie H.G., Meguid N.A., Khadrawy Y.A. Protective effect of ashwagandha (Withania somnifera) against neurotoxicity induced by aluminum chloride in rats. Asian Pac. J. Trop. Biomed. 2018;8:59\u201366."}, {"Citation": "Pandey A., Bani S., Dutt P., Satti N.K., Suri K.A., Qazi G.N. Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine. 2018;102:211\u2013221. doi: 10.1016/j.cyto.2017.10.019.", "ArticleIdList": ["10.1016/j.cyto.2017.10.019", "29108796"]}, {"Citation": "Zhu J., Park S., Jeong K.H., Kim W.J. Withanolide-A treatment exerts a neuroprotective effect via inhibiting neuroinflammation in the hippocampus after pilocarpine-induced status epilepticus. Epilepsy Res. 2020;165:106394. doi: 10.1016/j.eplepsyres.2020.106394.", "ArticleIdList": ["10.1016/j.eplepsyres.2020.106394", "32540785"]}, {"Citation": "Atluri V.S.R., Tiwari S., Rodriguez M., Kaushik A., Yndart A., Kolishetti N., Yatham M., Nair M. Inhibition of Amyloid-Beta production, associated neuroinflammation, and Histone Deacetylase 2-mediated epigenetic modifications prevent neuropathology in Alzheimer\u2019s disease in vitro Model. Front. Aging Neurosci. 2020;11:342. doi: 10.3389/fnagi.2019.00342.", "ArticleIdList": ["10.3389/fnagi.2019.00342", "PMC6974446", "32009938"]}, {"Citation": "Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Saecker A., Griep A., Axt D., Remus A., Tzeng T.C., et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674\u2013678. doi: 10.1038/nature11729.", "ArticleIdList": ["10.1038/nature11729", "PMC3812809", "23254930"]}, {"Citation": "Khalil H.M., Eliwa H.A., El-Shiekh R.A., Al-Mokaddem A.K., Hassan M., Tawfek A.M., El-Maadawy W.H. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of Nrf2/HO-1 and mitigation of NF-\u03baB/MAPK signaling pathways. J. Ethnopharmacol. 2021;277:114141. doi: 10.1016/j.jep.2021.114141.", "ArticleIdList": ["10.1016/j.jep.2021.114141", "33905819"]}, {"Citation": "Epuri V., Prathap L., Reddy V., Krishnan M. Anti oxidative/neuro-inflammation properties of Withania somnifera root extract on rotenone induced stress in rat brain. Bioinformation. 2023;19:729.", "ArticleIdList": ["PMC10598367", "37885788"]}, {"Citation": "Kaur T., Kaur G. Withania somnifera as a potential candidate to ameliorate high fat diet-induced anxiety and neuroinflammation. J. Neuroinflamm. 2017;14:201. doi: 10.1186/s12974-017-0975-6.", "ArticleIdList": ["10.1186/s12974-017-0975-6", "PMC5639730", "29025435"]}, {"Citation": "Gupta M., Kaur G. Withania somnifera as a potential anxiolytic and anti-inflammatory candidate against systemic lipopolysaccharide-induced neuroinflammation. Neuromolecular Med. 2018;20:343\u2013362. doi: 10.1007/s12017-018-8497-7.", "ArticleIdList": ["10.1007/s12017-018-8497-7", "29846872"]}, {"Citation": "Sun G.Y., Li R., Cui J., Hannink M., Gu Z., Fritsche K.L., Simonyi A. Withania somnifera and its withanolides attenuate oxidative and inflammatory responses and up-regulate antioxidant responses in BV-2 microglial cells. Neuromolecular Med. 2016;18:241\u2013252. doi: 10.1007/s12017-016-8411-0.", "ArticleIdList": ["10.1007/s12017-016-8411-0", "27209361"]}, {"Citation": "Gupta M., Kaur G. Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic in-flammation. BMC Complement. Altern. Med. 2019;19:217. doi: 10.1186/s12906-019-2635-0.", "ArticleIdList": ["10.1186/s12906-019-2635-0", "PMC6694620", "31416451"]}, {"Citation": "Chengappa K.R., Brar J.S., Gannon J.M., Schlicht P.J. Adjunctive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: A randomized, double-blind, placebo-controlled study. J. Clin. Psychiatry. 2018;79:22496. doi: 10.4088/JCP.17m11826.", "ArticleIdList": ["10.4088/JCP.17m11826", "29995356"]}, {"Citation": "Dutta K., Patel P., Rahimian R., Phaneuf D., Julien J.P. Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Neurotherapeutics. 2017;14:447\u2013462. doi: 10.1007/s13311-016-0499-2.", "ArticleIdList": ["10.1007/s13311-016-0499-2", "PMC5398980", "27928708"]}, {"Citation": "Kumar S., Phaneuf D., Julien J.P. Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD. Neurotherapeutics. 2021;18:286\u2013296. doi: 10.1007/s13311-020-00952-0.", "ArticleIdList": ["10.1007/s13311-020-00952-0", "PMC8116414", "33078279"]}, {"Citation": "Zeng K.W., Zhang T., Fu H., Liu G.X., Wang X.M. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-\u03baB signaling pathway in lipopolysaccharide-induced microglia. Eur. J. Pharmacol. 2012;692:29\u201337. doi: 10.1016/j.ejphar.2012.05.030.", "ArticleIdList": ["10.1016/j.ejphar.2012.05.030", "22698579"]}, {"Citation": "Edwards D., Heufelder A., Zimmermann A. Therapeutic Effects and Safety of Rhodiola rosea Extract WS\u00ae 1375 in Subjects with Life-stress Symptoms\u2013Results of an Open-label Study. Phytother. Res. 2012;26:1220\u20131225. doi: 10.1002/ptr.3712.", "ArticleIdList": ["10.1002/ptr.3712", "22228617"]}, {"Citation": "Tandon N., Yadav S.S. Safety and clinical effectiveness of Withania somnifera (Linn.) Dunal root in human ailments. J. Ethnopharmacol. 2020;255:112768. doi: 10.1016/j.jep.2020.112768.", "ArticleIdList": ["10.1016/j.jep.2020.112768", "32201301"]}, {"Citation": "Schmidt M., Thomsen M., Kelber O., Kraft K. Botanics: Targets and Therapy. Taylor & Francis; Abingdon, UK: 2014. Myths and facts in herbal medicines: Eleutherococcus senticosus (Siberian ginseng) and its contraindication in hypertensive patients; pp. 27\u201332."}, {"Citation": "Kim D.S., Baek H.I., Ha K.C., Cha Y.S., Park S.J. Efficacy and safety of Omija (Schisandra chinensis) extract mixture on the improvement of hyperglycemia: A randomized, double-blind, and placebo-controlled clinical trial. Nutrients. 2022;14:3159. doi: 10.3390/nu14153159.", "ArticleIdList": ["10.3390/nu14153159", "PMC9370295", "35956334"]}]}], "History": [{"Year": "2024", "Month": "1", "Day": "16"}, {"Year": "2024", "Month": "2", "Day": "7"}, {"Year": "2024", "Month": "2", "Day": "12"}, {"Year": "2024", "Month": "2", "Day": "26", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "2", "Day": "24", "Hour": "11", "Minute": "44"}, {"Year": "2024", "Month": "2", "Day": "24", "Hour": "1", "Minute": "14"}, {"Year": "2024", "Month": "2", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["38398618", "PMC10891670", "10.3390/molecules29040866", "molecules29040866"]}}]}